Tips on using this search form
- All search terms are case-insensitive
- If you specify more than one search option (e.g. you search for both "Authors" and "Paper title") then the publications returned will be those that match all of your search terms
- To reset the search form, click here
- Currently displaying 121 - 140 of 2525 publications
Abstract B124: YTHDC1 inhibition as a therapeutic strategy with potent preclinical activity alone and in combination with BCL-2 inhibitors
Molecular Cancer Therapeutics
(2025)
24
B124
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(doi: 10.21203/rs.3.rs-7375981/v1)
Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes
Translational Neurodegeneration
(2025)
14
52
(doi: 10.1186/s40035-025-00507-3)
Size of biomolecular condensates dictates fate in liquid–solid phase transitions through amorphous–amyloid competition
(2025)
(doi: 10.26434/chemrxiv-2025-6xwcg)
Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau
FEBS Letters
(2025)
599
2768
(doi: 10.1002/1873-3468.70141)
Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue
Nature Biomedical Engineering
(2025)
10
1222
(doi: 10.1038/s41551-025-01496-4)
Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
Communications Chemistry
(2025)
8
284
(doi: 10.1038/s42004-025-01659-z)
Advances in Proximity-Assisted Bioconjugation.
Accounts of Chemical Research
(2025)
58
2939
(doi: 10.1021/acs.accounts.5c00368)
Optofluidic Waveguides for the Label-Free Study of Silk Protein Aggregates
ACS omega
(2025)
10
46115
(doi: 10.1021/acsomega.5c07826)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(doi: 10.21203/rs.3.rs-7657706/v1)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(doi: 10.1101/2025.09.17.676873)
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay.
J Am Chem Soc
(2025)
147
35942
(doi: 10.1021/jacs.5c12812)
Transcript Identification Using Arrayed Hydrogels With TrapFISH (Adv. Mater. Technol. 18/2025)
Advanced Materials Technologies
(2025)
10
e70330
(doi: 10.1002/admt.70330)
Tumour-specific STING agonist synthesis via a two-component prodrug system
Nature Chemistry
(2025)
17
1941
(doi: 10.1038/s41557-025-01930-9)
Dissecting the molecular origins of opalescence and phase separation in mAb formulations and their relation to aggregation
(2025)
(doi: 10.1101/2025.08.29.672998)
Im-seq: Multimodal droplet barcoding enables high-throughput linking of single-cell imaging and gene expression
(2025)
(doi: 10.1101/2025.09.01.672798)
Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson’s disease
(2025)
(doi: 10.1101/2025.08.25.671921)
Rapid elongation drives the exceptionally fast aggregation of medin, the most common localized human amyloid
(2025)
(doi: 10.21203/rs.3.rs-6476074/v1)
Direct Observation of the Conformational Transitions in Tau and Their Correlation with Phase Behavior.
Jacs Au
(2025)
5
4268
(doi: 10.1021/jacsau.5c00625)